Citation Tools

Download PDFPDF

Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

Download to a citation manager

Cite this article as:
Fiedler W, Stoeger H, Perotti A, et al
Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours